Tolerance of Intraperitoneal (IP) Nivolumab After Extensive Debulking Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Ovarian Carcinoma
Clinical trial NCT03959761 · COMPLETED
Trial details
- NCT number
- NCT03959761
- Sponsor
- Hospices Civils de Lyon
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-17
- Primary completion
- 2022-10-03
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.